NCT03397563

Brief Summary

Cluster headache is also called suicide headache due to excruciating nocturnal attacks. There are few treatment options available. Inhalation of oxygen has shown to abort the attacks. Continuous positive airway pressure (CPAP) is a machine used during sleep to treat respiratory failure. Automatic CPAP machines adjust the air pressure through the night to keep the upper airways patent. Single reports have shown a high prevalence of obstructive sleep apnea in people suffering from cluster headache, and positive effects of CPAP treatment, but no randomized controlled trial has been conducted so far. If proven effective CPAP would make an affordable treatment option for many patients within the existing healthcare system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 4, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 12, 2018

Completed
4 days until next milestone

Study Start

First participant enrolled

January 16, 2018

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 21, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 21, 2019

Completed
Last Updated

March 31, 2020

Status Verified

March 1, 2020

Enrollment Period

1.6 years

First QC Date

January 4, 2018

Last Update Submit

March 30, 2020

Conditions

Keywords

Continuous Positive Airway PressureSleep Apnea, ObstructivePolysomnography

Outcome Measures

Primary Outcomes (2)

  • change from baseline in number of cluster headache attacks per week at week 9-12

    12 weeks

  • change from baseline in number of cluster headache attacks per week at week 21-24

    24 weeks

Secondary Outcomes (20)

  • Change from baseline in the number of nightly cluster attacks per week at week 9-12

    12 weeks

  • Change from baseline in the number of nightly cluster attacks per week at week 21-24

    24 weeks

  • Change from baseline in cluster headache start time per week at week 9-12

    12 weeks

  • Change from baseline in cluster headache start time per week at week 21-24

    24 weeks

  • Change from baseline in the number of days with cluster headache per week at week 9-12

    12 weeks

  • +15 more secondary outcomes

Study Arms (2)

CPAP treatment

EXPERIMENTAL

Continuous Positive Airway Pressure (CPAP)

Device: Continuous Positive Airway PressureDevice: sham Continuous Positive Airway Pressure

Sham-CPAP treatment

SHAM COMPARATOR

sham Continuous Positive Airway Pressure (sham-CPAP)

Device: Continuous Positive Airway PressureDevice: sham Continuous Positive Airway Pressure

Interventions

standard automatic CPAP machine set on optimal automatic pressure

Also known as: CPAP
CPAP treatmentSham-CPAP treatment

CPAP machine with pressure set below effective impact, i.e. low pressure of 4 cm H2O and adjustment of the ventilation mask

Also known as: sham-CPAP
CPAP treatmentSham-CPAP treatment

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Fulfils the diagnostic criteria for chronic cluster headache according to ICHD-3 beta 3.1.2.
  • is able to separate cluster headache attacks from other types of headache.
  • agrees to maintain current preventive headache and sleep medication regimens (no change in type, frequency, or dose) during the whole study period.
  • Signed informed consent.

You may not qualify if:

  • disorders with contraindications for use of continuous positive airway pressure (e.g. unable to remove the ventilation mask due to a movement disorders).
  • Nightly cluster headache attacks
  • Pregnancy or planned pregnancy
  • Severe depression or other psychiatric disorder that may interfere with the treatment.
  • Abuse of alcohol or illicit drugs.
  • Other severe chronic pain conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Olavs Hospital

Trondheim, Norway

Location

Related Publications (1)

  • Gravdahl GB, Aakeroy L, Stovner LJ, Engstrom M, Muller KI, Bjork MH, Tronvik E. Continuous positive airway pressure in cluster headache: A randomized, placebo-controlled, triple-blind, crossover study. Cephalalgia. 2023 Jan;43(1):3331024221128273. doi: 10.1177/03331024221128273.

MeSH Terms

Conditions

Cluster HeadacheChronic DiseaseSleep Apnea, Obstructive

Interventions

Continuous Positive Airway Pressure

Condition Hierarchy (Ancestors)

Trigeminal Autonomic CephalalgiasHeadache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsSleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake Disorders

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Geirmund Unsgård, MD PhD prof

    St. Olavs Hospital

    STUDY DIRECTOR
  • Erling Tronvik, MD PhD

    Norwegian University of Science and Technology

    PRINCIPAL INVESTIGATOR
  • Lars Jacob Stovner, MD prof

    Norwegian Advisory Unit on Headaches

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2018

First Posted

January 12, 2018

Study Start

January 16, 2018

Primary Completion

August 21, 2019

Study Completion

August 21, 2019

Last Updated

March 31, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations